Skip to main content
. 2012 Mar 16;27(8):901–910. doi: 10.1007/s11606-012-2027-3

Table 1.

Sample Persons' Characteristics

Characteristics Total Development Validation
No. ( weighted % ) N = 7373 N = 4434 N = 2939
Age
  ≥70–<75 3607(49.5) 2183(49.7) 1424(49.3)
  ≥75–<80 2016(27.4) 1202(27.2) 814(27.7)
  ≥80–<85 1143(15.2) 685(15.1) 458(15.2)
  ≥85 607(7.9) 364(8.0) 243(7.9)
Gender
  Female 4678(62.9) 2835(63.3) 1843(62.4)
  Male 2695(37.1) 1599(36.7) 1096(37.6)
Race
  White 6340(88.8) 3822(89.2) 2518(88.3)
  Black 762(7.4) 463(7.3) 299(7.5)
  Other 271(3.8) 149(3.5) 122(4.3)
High school graduate
  No 3030(40.0) 1820(39.9) 1210(40.2)
  Yes 4343(60.0) 2614(60.1) 1729(59.8)
Marital status
  Married 3860(53.0) 2332(53.3) 1528(52.5)
  Unmarried 3513(47.0) 2102(46.7) 1411(47.5)
Health status
  Excellent 1119(15.6) 672(15.7) 447(15.3)
  Very Good 1762(24.2) 1086(24.7) 676(23.5)
  Good 2583(35.0) 1523(34.3) 1060(36.1)
  Fair 1342(17.7) 816(17.9) 526(17.3)
  Poor 567(7.5) 337(7.3) 230(7.8)
Hypertension
  No 4174(57.2) 2510(57.3) 1664(57.1)
  Yes 3199(42.8) 1924(42.7) 1275(42.9)
Diabetes
  No 6502(88.4) 3890(88.1) 2612(88.8)
  Yes 871(11.6) 544(11.9) 327(11.2)
Cancer
  No 6181(83.4) 3714(83.3) 2467(83.7)
  Yes 1192(16.6) 720(16.7) 472(16.3)
Chronic bronchitis or emphysema
  No 6713(90.9) 4031(90.6) 2682(91.2)
  Yes 660(9.1) 403(9.4) 257(8.8)
Asthma
  No 6960(94.5) 4180(94.3) 2780(94.8)
  Yes 413(5.5) 254(5.7) 159(5.2)
Coronary artery disease
  No 5975(80.9) 3593(80.8) 2382(81.2)
  Yes 1398(19.1) 841(19.2) 557(18.8)
Other heart disease
  No 6883(93.3) 4153(93.6) 2730(92.9)
  Yes 490(6.7) 281(6.4) 209(7.1)
Stroke
  No 6826(92.7) 4104(92.7) 2722(92.6)
  Yes 547(7.3) 330(7.3) 217(7.4)
Arthritis
  No 4012(54.5) 2400(54.0) 1612(55.2)
  Yes 3361(45.5) 2034(46.0) 1327(44.8)
Major depression*
  No 7264(99.3) 4365(99.2) 2899(99.3)
  Yes 52(0.7) 30(0.8) 22(0.7)
Blindness in both eyes*
  No 7172(98.5) 4312(98.6) 2860(98.5)
  Yes 112(1.5) 63(1.4) 49(1.5)
Deafness in both ears*
  No 6807(93.4) 4076(93.0) 2731(94.0)
  Yes 467(6.6) 297(7.0) 170(6.0)
Ever had broken hip*
  No 6995(96.0) 4186(95.6) 2809(96.5)
  Yes 294(4.0) 191(4.4) 103(3.5)
Fall*
  No 5864(79.9) 3530(79.8) 2334(80.0)
  Yes 1463(20.1) 876(20.2) 587(20.0)
Proxy use
  No 6226(84.7) 3745(84.6) 2481(84.8)
  Yes 1147(15.3) 689(15.4) 458(15.2)
IADL stage
  No limitations 5134(70.0) 3090(70.0) 2044(69.8)
  Mild limitations 1232(16.7) 750(16.9) 482(16.4)
  Moderate limitations 454(6.0) 275(6.0) 179(5.9)
  Severe limitations 439(5.8) 255(5.6) 184(6.2)
  Complete limitations 114(1.5) 64(1.4) 50(1.7)
1-year mortality
  No 7103(96.3) 4285(96.7) 2818(95.9)
  Yes 270(3.7) 149(3.3) 121(4.1)
5-year mortality
  No 5640(76.7) 3407(77.2) 2233(76.0)
  Yes 1733(23.3) 1027(22.8) 706(24.0)
10-year mortality
  No 3675(50.2) 2220(50.5) 1455(49.7)
  Yes 3698(49.8) 2214(49.5) 1484(50.3)

*Sample size is slightly less for these variables due to missing data: major depression (N = 7316, 4395, and 2921); blindness in both eyes (N = 7284, 4375, and 2909); deafness in both ears (N = 7274, 4373, and 2901); ever had broken hip (N = 7289, 4377, and 2912); fall (N = 7327, 4406, and 2921)